| Authors: |
Silvestro A; GSK, Waltham, MA., Baden J; Bristol Myers Squibb, Lawrence Township, NJ., Billings K; Streck, La Vista, NE., Bramlett K; Quest Diagnostics, Secaucus, NJ., Corner A; Bio-Rad, Pleasanton, CA., Danek T; Tempus AI, Chicago, IL., Deras I; Formerly with Illumina, San Diego, CA., Dickey J; Labcorp (PGDx), Baltimore, MD., Godsey JH; Formerly with Quest Diagnostics, Secaucus, NJ., Guan L; Illumina, San Diego, CA., Hutchinson T; Freenome, San Francisco, CA., Johann DJ; University of Arkansas, Little Rock, AR., Lee JSH; University of Southern California, Los Angeles, CA., Lin CJ; Freenome, San Francisco, CA., Lococo JS; Illumina, San Diego, CA., Lopez Ramos D; BLOODPAC, Chicago, IL., Richardson AO; Freenome, San Francisco, CA., Stetson D; Astrazeneca, Wilmington, DE., Wenz P; Illumina, San Diego, CA., Leiman LC; BLOODPAC, Chicago, IL. |
